What is Crosstree?
Founded in 2004 and headquartered in Tampa, Florida, with a strategic footprint in New York City, Crosstree operates as a specialized investment bank focused exclusively on the health science industry. The firm provides comprehensive financial services, including mergers and acquisitions (M&A), recapitalization, and growth financing. By maintaining a deep focus on the complexities of health science, Crosstree serves as a critical intermediary for companies navigating the intersection of clinical innovation and capital markets. Its expertise in structuring complex transactions has made it a go-to partner for organizations seeking to optimize their balance sheets and execute long-term growth strategies.
How much funding has Crosstree raised?
Crosstree has raised a total of $496K across 2 funding rounds:
Debt
$150K
Debt
$346K
Debt (2020): $150K with participation from PPP
Debt (2021): $346K led by PPP
Key Investors in Crosstree
PPP
Public-Private Partnership
What's next for Crosstree?
With the successful completion of this late-stage funding, Crosstree is well-positioned to scale its advisory operations and expand its reach within the global health science ecosystem. The firm is expected to utilize this capital to enhance its service offerings, potentially deepening its bench of industry experts and strengthening its presence in key financial hubs. As the health science sector faces increasing pressure for consolidation and strategic realignment, Crosstree's ability to provide sophisticated financial guidance will be paramount. The firm's trajectory suggests a continued focus on high-value transactions, ensuring that it remains at the forefront of health science capital markets and strategic advisory services.
See full Crosstree company page
